StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — Prakash Gaba

BUYAarti Pharmalabs Limited
Aarti Pharmalabs share price target & all analyst calls

byPrakash GabaHorizon: Swing (≤2wk)29 Oct 2026via CNBC Awaaz.

Entry₹934.2Inferred
Target₹975
Total upside +4.37% (call closed)
Stop loss₹900-3.66% risk
Exit₹900Stop-loss hit — time not yet verified
Stop-loss hit-3.66%
Follow Prakash Gaba for new calls(30% target hit, 300 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 227 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 2:00 pm IST
0 supporting2 neutral1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (2)

Appointment of Smt. Vibha Thakkar as the new Chief Financial Officer.

NSE · Appointment·28 Oct · today

(opens in new tab)

Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·28 Oct · today

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·29 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Pharmalabs

All analyst calls on Aarti Pharmalabs

More from Prakash Gaba

Every call and its outcome